Tumor promoting activity of insulin can be mediated by insulin receptor (INSR) as well as cross-activation of the insulin-like growth factor 1 receptor (IGF1R) family, resulting in activation of downstream signaling cascades [3, 7]. This evidence concerns the gene INS and neoplasm.